Today sclerotherapy is the elective treatment for most cases of telangiectases. The main exceptions are "red" telangiectases, those with a caliber <0.3 mm and those with high flow, which do not respond to sclerotherapy or are aggravated by it as they require high concentrations of locally and generally toxic sclerosant solutions.The aim of the study was to remove all types of telangiectases, reduce doses and concentrations of sclerosant drugs, reduce risks and side effects, improve course and recovery time and increase long-term effects.Material and methods. We treated the types of telangiectases above-mentioned (563 cases on the legs, 375 on the face) with laser photocoagulation and two different techniques, called Laser-Video Sclerotherapy (LVST) and Laser-Video Therapy (LVT), utilizing also the videocapillaroscope coupled with diode laser 532 nm.Results. All types of telangiectases of the face disappeared, and 22 cases only haven't results on the legs. Relapses had be minus than 10% of cases of legs, and minus than 7% on the face. No side effectives appears in any cases.Conclusions. We achieved four on five objectives purposed, using LVT and LSVT in selected cases. Relapses are the greater problem still no-eliminated.